EnfraGen, LLC, a developer, owner, and operator of specialized sustainable, renewable power and grid stability assets in Latin America owned by Glenfarne Energy Transition,...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced the initiation of a Phase 2 trial...
After two years of rigorous research and development, Climax is introducing its first "zero-compromise" plant-based products to select audiences in Los Angeles, New York...
